{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T05:53:44Z","timestamp":1775627624088,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.vaccine.2020.02.059","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T17:48:14Z","timestamp":1583516894000},"page":"3280-3291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Hong","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karuna P.","family":"Karunakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhou","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Queenie","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caren","family":"Rose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard J.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143304","article-title":"Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.059_b0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/infdis\/163.2.233","article-title":"Cofactors in male-female sexual transmission of human immunodeficiency virus type 1","volume":"163","author":"Plummer","year":"1991","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.059_b0015","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.285.1.47","article-title":"Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma","volume":"285","author":"Anttila","year":"2001","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.059_b0020","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1086\/497341","article-title":"The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection","volume":"192","author":"Brunham","year":"2005","journal-title":"J Infect Dis"},{"issue":"15","key":"10.1016\/j.vaccine.2020.02.059_b0025","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.vaccine.2013.01.024","article-title":"Chlamydia trachomatis control requires a vaccine","volume":"31","author":"Brunham","year":"2013","journal-title":"Vaccine"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2020.02.059_b0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1099\/jmm.0.05093-0","article-title":"Chlamydial vaccine development","volume":"52","author":"Longbottom","year":"2003","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.059_b0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00007435-197804000-00011","article-title":"The potential for vaccine against infection of the genital tract with Chlamydia trachomatis","volume":"5","author":"Grayston","year":"1978","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.vaccine.2020.02.059_b0040","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/0002-9394(67)94155-4","article-title":"Trachoma vaccine studies in monkeys","volume":"63(5):Suppl","author":"Wang","year":"1967","journal-title":"Am J Ophthalmol"},{"issue":"14","key":"10.1016\/j.vaccine.2020.02.059_b0045","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.vaccine.2013.10.016","article-title":"Towards a safe and effective Chlamydial vaccine: lessons from the eye","volume":"32","author":"Mabey","year":"2014","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.059_b0050","doi-asserted-by":"crossref","first-page":"4027","DOI":"10.4049\/jimmunol.179.6.4027","article-title":"Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease","volume":"179","author":"O'Connell","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.059_b0055","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1084\/jem.20111266","article-title":"A live-attenuated Chlamydial vaccine protects against trachoma in nonhuman primates","volume":"208","author":"Kari","year":"2011","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.059_b0060","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1128\/IAI.00841-15","article-title":"Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D","volume":"83","author":"Qu","year":"2015","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2020.02.059_b0065","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1128\/IAI.69.10.6240-6247.2001","article-title":"Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge","volume":"69","author":"Pal","year":"2001","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0070","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.4049\/jimmunol.0804375","article-title":"Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine","volume":"182","author":"Kari","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.059_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30279-8","article-title":"Safety and immunogenicity of the Chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial","author":"Abraham","year":"2019","journal-title":"The Lancet Infectious diseases"},{"issue":"6","key":"10.1016\/j.vaccine.2020.02.059_b0080","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.4049\/jimmunol.1002952","article-title":"Immunization with live and dead Chlamydia muridarum induces different levels of protective immunity in a murine genital tract model: correlation with MHC class II peptide presentation and multifunctional Th1 cells","volume":"186","author":"Yu","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.059_b0085","first-page":"9","article-title":"An Adaptive Chlamydia trachomatis-Specific IFN-gamma-Producing CD4(+) T Cell Response Is Associated With Protection Against Chlamydia Reinfection in Women","volume":"2018","author":"Bakshi","year":"1981","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.059_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058565","article-title":"Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity","volume":"8","author":"Vicetti Miguel","year":"2013","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0095","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/IAI.00574-08","article-title":"Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein","volume":"76","author":"Pal","year":"2008","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.059_b0100","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1128\/IAI.00881-10","article-title":"Vaccination against Chlamydia genital infection utilizing the murine C. muridarum model","volume":"79","author":"Farris","year":"2011","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.059_b0105","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.4049\/jimmunol.180.4.2459","article-title":"Immunoproteomic discovery of novel T cell antigens from the obligate intracellular pathogen Chlamydia","volume":"180","author":"Karunakaran","year":"2008","journal-title":"J Immunol"},{"issue":"18","key":"10.1016\/j.vaccine.2020.02.059_b0110","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.vaccine.2015.02.055","article-title":"Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine","volume":"33","author":"Karunakaran","year":"2015","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2020.02.059_b0115","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1016\/j.vaccine.2014.06.002","article-title":"Evaluation of a multisubunit recombinant polymorphic membrane protein and major outer membrane protein T cell vaccine against Chlamydia muridarum genital infection in three strains of mice","volume":"32","author":"Yu","year":"2014","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.059_b0120","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1128\/IAI.06338-11","article-title":"Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice","volume":"80","author":"Yu","year":"2012","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.059_b0125","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/JB.01628-09","article-title":"Identification of Chlamydia trachomatis outer membrane complex proteins by differential proteomics","volume":"192","author":"Liu","year":"2010","journal-title":"J Bacteriol"},{"issue":"9","key":"10.1016\/j.vaccine.2020.02.059_b0130","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/iai.58.9.3101-3108.1990","article-title":"Protection of sheep against Chlamydia psittaci infection with a subcellular vaccine containing the major outer membrane protein","volume":"58","author":"Tan","year":"1990","journal-title":"Infect Immun"},{"issue":"5259","key":"10.1016\/j.vaccine.2020.02.059_b0135","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.059_b0140","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1021\/pr050385q","article-title":"Modular stop and go extraction tips with stacked disks for parallel and multidimensional Peptide fractionation in proteomics","volume":"5","author":"Ishihama","year":"2006","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.059_b0145","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1038\/s41598-017-07999-8","article-title":"The [PSI (+)] yeast prion does not wildly affect proteome composition whereas selective pressure exerted on [PSI (+)] cells can promote aneuploidy","volume":"7","author":"Chan","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0150","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.4049\/jimmunol.175.5.3197","article-title":"NK T cell activation promotes Chlamydia trachomatis infection in vivo","volume":"175","author":"Bilenki","year":"2005","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0155","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1128\/IAI.01374-09","volume":"78","author":"Yu","year":"2010","journal-title":"Infect Immun"},{"issue":"18","key":"10.1016\/j.vaccine.2020.02.059_b0160","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1128\/JVI.76.18.9002-9010.2002","article-title":"van Drunen Littel-van den Hurk S: The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides","volume":"76","author":"Ioannou","year":"2002","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0165","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1067\/S0002-9378(03)00755-5","article-title":"Serum antibody response to the heat shock protein 60 of Chlamydia trachomatis in women with developing cervical cancer","volume":"189","author":"Paavonen","year":"2003","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.059_b0170","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1128\/iai.59.8.2624-2630.1991","article-title":"Neutralization of Chlamydia trachomatis: kinetics and stoichiometry","volume":"59","author":"Peeling","year":"1991","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010768","article-title":"Protection against Chlamydia promoted by a subunit vaccine (CTH1) compared with a primary intranasal infection in a mouse genital challenge model","volume":"5","author":"Olsen","year":"2010","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.059_b0180","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1002\/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D","article-title":"Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera","volume":"20","author":"Sanchez-Campillo","year":"1999","journal-title":"Electrophoresis"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0185","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1128\/IAI.02576-14","article-title":"Plasmid-encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice","volume":"82","author":"Liu","year":"2014","journal-title":"Infect Immun"},{"issue":"22","key":"10.1016\/j.vaccine.2020.02.059_b0190","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1128\/JB.00847-10","article-title":"Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen","volume":"192","author":"Chen","year":"2010","journal-title":"J Bacteriol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.059_b0195","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4049\/jimmunol.182.3.1602","article-title":"Novel Chlamydia muridarum T cell antigens induce protective immunity against lung and genital tract infection in murine models","volume":"182","author":"Yu","year":"2009","journal-title":"J Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2020.02.059_b0200","doi-asserted-by":"crossref","first-page":"9969","DOI":"10.1073\/pnas.1101756108","article-title":"Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines","volume":"108","author":"Finco","year":"2011","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.vaccine.2020.02.059_b0205","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.4049\/jimmunol.1001240","article-title":"A genome-wide profiling of the humoral immune response to Chlamydia trachomatis infection reveals vaccine candidate antigens expressed in humans","volume":"185","author":"Wang","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.02.059_b0210","first-page":"4(1)","article-title":"The Structure and Function of Type III Secretion Systems","author":"Notti","year":"2016","journal-title":"Microbiol Spectrum"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0215","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.4049\/jimmunol.1103032","article-title":"CD4+ T cells are necessary and sufficient to confer protection against Chlamydia trachomatis infection in the murine upper genital tract","volume":"189","author":"Gondek","year":"2012","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.059_b0220","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1128\/iai.65.8.3361-3369.1997","article-title":"Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge","volume":"65","author":"Pal","year":"1997","journal-title":"Infect Immun"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0225","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1099\/00221287-139-12-2965","article-title":"Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the Chlamydial agent of guinea-pig inclusion conjunctivitis","volume":"139","author":"Batteiger","year":"1993","journal-title":"J Gen Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.02.059_b0230","first-page":"1477","article-title":"A Chlamydial major outer membrane protein extract as a trachoma vaccine candidate","volume":"36","author":"Campos","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.059_b0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nri1551","article-title":"Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine","volume":"5","author":"Brunham","year":"2005","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.059_b0240","doi-asserted-by":"crossref","first-page":"7536","DOI":"10.4049\/jimmunol.175.11.7536","article-title":"A predominant role for antibody in acquired immunity to Chlamydial genital tract reinfection","volume":"175","author":"Morrison","year":"2005","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.059_b0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1046\/j.0019-2805.2001.01354.x","article-title":"Fc receptor regulation of protective immunity against Chlamydia trachomatis","volume":"105","author":"Moore","year":"2002","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2020.02.059_b0250","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1084\/jem.160.4.1102","article-title":"Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors","volume":"160","author":"Rock","year":"1984","journal-title":"J Exp Med"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.059_b0255","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/iai.57.1.299-301.1989","article-title":"Protective role of serum antibody in immunity to Chlamydial genital infection","volume":"57","author":"Rank","year":"1989","journal-title":"Infect Immun"},{"issue":"11","key":"10.1016\/j.vaccine.2020.02.059_b0260","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0264-410X(95)00017-U","article-title":"Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against Chlamydial genital tract infection","volume":"13","author":"Su","year":"1995","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.02.059_b0265","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/iai.63.12.4704-4714.1995","article-title":"Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection","volume":"63","author":"Cotter","year":"1995","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2020.02.059_b0270","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/OLQ.0b013e3181557c25","article-title":"Chlamydia antibodies, Chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: the PID Evaluation and Clinical Health (PEACH) Study","volume":"35","author":"Ness","year":"2008","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.02.059_b0275","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13103","article-title":"Anti-Chlamydia IgG and IgA are insufficient to prevent endometrial Chlamydia infection in women, and increased anti-Chlamydia IgG is associated with enhanced risk for incident infection","volume":"81","author":"Darville","year":"2019","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.02.059_b0280","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12866-016-0787-3","article-title":"Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research","volume":"16","author":"Wen","year":"2016","journal-title":"BMC Microbiol"},{"issue":"36","key":"10.1016\/j.vaccine.2020.02.059_b0285","doi-asserted-by":"crossref","first-page":"15121","DOI":"10.1074\/jbc.M117.784561","article-title":"Cell-free production of a functional oligomeric form of a Chlamydia major outer-membrane protein (MOMP) for vaccine development","volume":"292","author":"He","year":"2017","journal-title":"J Biol Chem"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20302826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:41:59Z","timestamp":1759401719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20302826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":57,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0264410X20302826"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Chlamydia outer membrane complex to recombinant outer membrane proteins as vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.02.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}